JAK2 and acquired polycythemia vera: JAK2 V617F mutation was observed in a majority of PV (Prchal, 2005) patients and a significant proportion of patients with other MPDs, including ET, IMF and some rare MPDs (Levine et al., 2005; James, 2005).